This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Reply to Misdiagnosis of Bipolar II Disorder as Major Depressive Order

David L. Dunner, MD, and Michael E. Thase, MD

Published: August 28, 2008

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Dr. Benazzi is quite correct that individuals with bipolardisorder (and especially bipolar II disorder) are more likely tohave recurrence of depressive episodes than patients with majordepression. He is also correct that subjects were entered into thePREVENT study1 on the basis of having depression meeting DSM-IV-TR criteria, and we agree that structured interviewsused to assess whether a patient has bipolar or recurrent majordepression can miss subtle forms of hypomania and wronglyclassify patients as unipolar when they are truly bipolar.However, the acute treatment phase of the PREVENT studytreated subjects with either venlafaxine (75-300 mg) or fluoxetine(20-60 mg).’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 69

Quick Links: Depression (MDD)

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...

Read More...